Literature DB >> 3375199

Interstitial deletion of chromosome 1 [del(1)(q25q32)] in an infant with prune belly sequence.

P R Scarbrough1, B Files, A J Carroll, R W Quinlan, S C Finley, W H Finley.   

Abstract

Relatively few cases of deletion 1q have been reported. These cases have been divided into three groups according to assigned breakpoints. They include proximal interstitial, intermediate interstitial, and terminal deletions. We present a male infant with an interstitial deletion of 1q with breakpoints determined by GTG banding as q25 and q32. Comparison with similar case reports suggests common physical features which include microcephaly, growth retardation, developmental delay, clinodactyly, and genital anomalies in affected males. However, no characteristic phenotypic appearance is definable. The infant also presented with prune belly sequence (PBS) with Potter facies. Fetal ascites, as noted in this case on prenatal ultrasound, appears to be an early factor in the pathogenesis of PBS. Therefore, detection of fetal ascites should suggest the presence of the PBS association and the need for more extensive prenatal evaluation.

Entities:  

Mesh:

Year:  1988        PMID: 3375199     DOI: 10.1002/pd.1970080302

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

Review 1.  ECM receptors in neuronal structure, synaptic plasticity, and behavior.

Authors:  Meghan E Kerrisk; Lorenzo A Cingolani; Anthony J Koleske
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

2.  Integrin α3 is required for late postnatal stability of dendrite arbors, dendritic spines and synapses, and mouse behavior.

Authors:  Meghan E Kerrisk; Charles A Greer; Anthony J Koleske
Journal:  J Neurosci       Date:  2013-04-17       Impact factor: 6.167

3.  Abl2/Arg controls dendritic spine and dendrite arbor stability via distinct cytoskeletal control pathways.

Authors:  Yu-Chih Lin; Mark F Yeckel; Anthony J Koleske
Journal:  J Neurosci       Date:  2013-01-30       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.